Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
NextPharma Oy
OY
Active
Y-tunnus 2968177-8
Niittyhaankatu 20, 33720
Tampere
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 7 years old
295 employees
Share
Finland
/
Companies
/
Manufacture of pharmaceutical preparations
/
NextPharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
46M
35M
23M
12M
0M
2021: 25M
25M
2021
2022: 30M (+20% vs 2021)
30M
+20%
2022
2023: 30M (0% vs 2022)
30M
0%
2023
2024: 31M (+3% vs 2023)
31M
+3%
2024
2025: 37M (+19% vs 2024)
37M
+19%
2025
EBITDA
EUR millions
17M
13M
9M
4M
0M
2021: 3M
3M
2021
2022: 14M (+367% vs 2021)
14M
+367%
2022
2023: 3M (-79% vs 2022)
3M
-79%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
37 277
31 347
29 958
30 190
24 524
Staff expenses
−16 763
−12 230
−10 949
−9 163
−8 595
EBITDA
−263
2 726
3 093
14 488
3 496
Depreciation & amort.
−1 820
−1 620
−1 538
−1 098
−343
EBIT
−2 084
1 107
1 555
13 390
3 153
Net financials
−1 108
−561
−678
−998
−870
Profit before tax
−3 950
75
−995
7 904
2 119
Tax
−15
15
−8
1 584
424
Net profit
−3 934
60
0
6 320
1 695
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
59 410
36 895
30 708
36 857
25 434
Equity
7 646
11 580
11 520
16 666
6 756
Long-term debt
30 122
10 246
6 951
13 198
13 038
Short-term debt
13 363
7 548
5 186
6 993
5 640
Total debt
43 485
17 794
12 137
20 191
18 678
Financial ratios
5-year trend
EBITDA margin
−0,7 %
This company
15,8 %
Market median
This company
Market median
104% below market
2021
2025
Equity ratio
12,9 %
This company
38,2 %
Market median
This company
Market median
66% below market
2021
2025
Return on equity
−51,5 %
This company
18,4 %
Market median
This company
Market median
380% below market
2021
2025
Net profit margin
−10,6 %
This company
8,1 %
Market median
This company
Market median
231% below market
2021
2025
Asset turnover
0,63×
This company
1,12×
Market median
This company
Market median
44% below market
2021
2025
Debt / equity
6,77×
This company
0,62×
Market median
This company
Market median
992% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on NextPharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
